Journal of cardiothoracic and vascular anesthesia
-
J. Cardiothorac. Vasc. Anesth. · Jun 1995
Randomized Controlled Trial Comparative Study Clinical TrialA comparison of the effects of tranexamic acid and low-dose aprotinin on blood loss and homologous blood usage in patients undergoing cardiac surgery.
To assess the relative efficacy of a "low-dose" aprotinin regimen and tranexamic acid on blood loss and homologous blood usage in patients undergoing primary cardiac surgery. ⋯ Tranexamic acid is as effective as low-dose aprotinin in the reduction of postoperative blood loss and homologous blood transfusion in patients undergoing primary cardiac surgery.
-
J. Cardiothorac. Vasc. Anesth. · Jun 1995
Atrioventricular sequential pacing using transesophageal atrial pacing in combination with a temporary DDD pacemaker for atrial tracking and ventricular pacing.
To determine whether atrioventricular (A-V) sequential pacing can be accomplished using transesophageal atrial pacing (TAP) in combination with a temporary DDD pacemaker for tracking the TAP stimuli and pacing the ventricle via temporary epicardial electrodes. ⋯ This report demonstrates that it is possible to A-V sequentially pace using TAP in combination with a temporary DDD pacemaker for tracking the TAP stimulus and pacing the ventricle via temporary epicardial leads. This technique may be useful when A-V sequential pacing is needed and functional temporary atrial leads are not available.
-
J. Cardiothorac. Vasc. Anesth. · Jun 1995
Randomized Controlled Trial Comparative Study Clinical TrialComparison of two different loading doses of milrinone for weaning from cardiopulmonary bypass.
To compare the hemodynamic effects, pharmacokinetic profiles, and the need for vasoactive agents between a low (20 micrograms/kg during 15 minutes [group 1; n = 10]) and a high (40 micrograms/kg during 15 minutes [group 2; n = 10]) loading dose of milrinone. ⋯ The present results demonstrate that when milrinone is used during weaning from CPB, a loading dose of 20 micrograms/kg provided to similar hemodynamic support a loading dose of 40 micrograms/kg. The need for vasoconstrictive medication was significantly less in the group with the low loading dose.
-
J. Cardiothorac. Vasc. Anesth. · Jun 1995
Randomized Controlled Trial Clinical TrialEffects of aprotinin on blood loss, heparin monitoring tests, and heparin doses in patients undergoing coronary artery bypass surgery.
Evaluation of the effect of aprotinin on heparin monitoring tests, on heparin doses, and on perioperative blood loss in patients undergoing coronary artery bypass grafting. ⋯ Aprotinin significantly reduced blood loss during coronary artery bypass surgery and was associated with a slight reduction in the amount of heparin administered. Activated coagulation time and activated partial thromboplastin time were prolonged by the addition of aprotinin. Activated coagulation time and activated partial thromboplastin time were poorly correlated with heparin assays. On the other hand, two other clotting tests designed to monitor heparin therapy, namely Titrarine (Stago, Asnière, France) and Heptest (Haemachem, St. Louis, MO), gave very good correlation with amidolytic heparin assays and can be used during extracorporeal circulation. Thrombin time showed a good correlation with amidolytic heparin assays after protamine administration and can be useful to detect residual heparin after heparin neutralization by protamine.